Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
F1 champion Nico Rosberg doubles VC assets as celebrity-backed funds gain traction
F1 champion Nico Rosberg doubles VC assets as celebrity-backed funds gain traction Former Formula One world champion Nico Rosberg has raised $100m for his venture capital firm, Rosberg Ventures, expanding a platform that has become one of the largest technology...
Private equity investors offload $110bn of ageing fund stakes as exits stall
Private equity investors offload $110bn of ageing fund stakes as exits stall Private capital investors sold a record $110bn of stakes in ageing funds in 2025, as difficult exit conditions pushed limited partners to seek liquidity through the secondaries market,...
LGT Capital Partners anchors Guggenheim’s $250m private debt fund
LGT Capital Partners anchors Guggenheim’s $250m private debt fund Guggenheim Investments has closed a $250m private debt fund, with LGT Capital Partners leading commitments, as institutional investors continue to allocate capital to private credit strategies. The fund...




